Cargando…
Identification of a Selective G1-Phase Benzimidazolone Inhibitor by a Senescence-Targeted Virtual Screen Using Artificial Neural Networks()()
Cellular senescence is a barrier to tumorigenesis in normal cells, and tumor cells undergo senescence responses to genotoxic stimuli, which is a potential target phenotype for cancer therapy. However, in this setting, mixed-mode responses are common with apoptosis the dominant effect. Hence, more se...
Autores principales: | Bilsland, Alan E., Pugliese, Angelo, Liu, Yu, Revie, John, Burns, Sharon, McCormick, Carol, Cairney, Claire J., Bower, Justin, Drysdale, Martin, Narita, Masashi, Sadaie, Mahito, Keith, W. Nicol |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4611071/ https://www.ncbi.nlm.nih.gov/pubmed/26476078 http://dx.doi.org/10.1016/j.neo.2015.08.009 |
Ejemplares similares
-
A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds
por: Cairney, Claire J., et al.
Publicado: (2017) -
Cellular senescence and its effector programs
por: Salama, Rafik, et al.
Publicado: (2014) -
Cell-based screen for altered nuclear phenotypes reveals senescence progression in polyploid cells after Aurora kinase B inhibition
por: Sadaie, Mahito, et al.
Publicado: (2015) -
Synthesis and Biological Activities of Some Benzimidazolone Derivatives
por: Karale, B. K., et al.
Publicado: (2015) -
Redistribution of the Lamin B1 genomic binding profile affects rearrangement of heterochromatic domains and SAHF formation during senescence
por: Sadaie, Mahito, et al.
Publicado: (2013)